Lysophosphatidylcholine (LPC) as a pharmacological molecule for the reduction of tumor cell adhesion and metastasis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 1, 2011, Pages 75-77

  Alexander, M ^a,b,c   Schlesinger, M ^c   Jantscheff, P ^d   Massing, U ^d   Bendas, G ^c  

^a Life and Brain Center   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Cellular adhesion molecules; Lysophosphatidylcholine (LPC); Lysophospholipids; Signal transduction; Tumor cell metastasis

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AGED; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYDROGENATION; METASTASIS; METASTASIS INHIBITION; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; CELL ADHESION; CELL LINE, TUMOR; HUMANS; LYSOPHOSPHATIDYLCHOLINES; NEOPLASM METASTASIS; NEOPLASMS;

EID: 78650848875     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP49075     Document Type: Conference Paper

References (5)

1. Jantscheff P, Schlesinger M, Fritzsche J, Taylor LA, Graeser R, Kirfel G, Fürst DO, Massing U, Bendas G. Lysophosphatidylcholine inhibits B16.F10 melanoma metastatic spread in vivo by interfering with VLA-4 and P-selectin cell binding. Mol Canc Ther. Accepted.
2. Tybulewicz VL, Henderson RB. Rho family GTPases and their regulators in lymphocytes. Nat Rev Immunol. 2009; 9: 630-644.
3. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev. 2009; 28: 5-14.
4. Bartolome RA, Wright N, Molina-Ortiz I, Sanchez-Luque FJ, Teixido J. Activated GA13 impairs cell invasiveness through p190RhoGAP mediated inhibition of RhoA activity. Cancer Res. 2008; 68: 20.
5. Alexander M, Schlesinger M, Jantscheff P, Massing U, Bendas G. Reduction in human melanoma cell adhesion receptor activity by lysophosphatidlycholine (LPC) treatment - functional characterization and signal pathway analyses. Int J Clin Pharm Ther. 2010; 48: 478-480.